Medicine and Dentistry
Infection
100%
In Vitro
100%
Mycobacterium abscessus
100%
Amikacin
100%
Mycobacteria
66%
Antibiotics
66%
Side Effect
33%
Exhalation
33%
Antibiotic Therapy
33%
Antimicrobial Activity
33%
Antimicrobial Agent
33%
Cystic Fibrosis
33%
Lung Infection
33%
Respiratory Tract Infection
33%
Pathogenesis
33%
Soft Tissue Infection
33%
Keyphrases
Amikacin
100%
Mycobacterium Abscessus
100%
In Vitro Synergy
100%
Manuka Honey
100%
Nebulized Therapy
100%
Multidrug-resistant
28%
Mycobacterium
28%
Wide-ranging
14%
Antibiotics
14%
Therapeutic Potential
14%
Cystic Fibrosis
14%
Inhalation
14%
Success Rate
14%
Drug Treatment
14%
Treatment Regimen
14%
Antimicrobial Activity
14%
Skin Tissue
14%
Soft Tissue Infection
14%
Opportunistic Pathogens
14%
Antibiotic Treatment
14%
Antibiotic Combination
14%
New Therapeutics
14%
Microbroth Dilution
14%
Pulmonary Infection
14%
Respiratory Infection
14%
Checkerboard Assay
14%
Inhaled Antibiotics
14%
Medicinal Properties
14%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Mycobacterium abscessus
100%
Amikacin
100%
Antibiotics
66%
Mycobacteria
66%
Side Effect
33%
Antimicrobial Agent
33%
Cystic Fibrosis
33%
Lung Infection
33%
Respiratory Tract Infection
33%
Pathogenesis
33%
Soft Tissue Infection
33%
Immunology and Microbiology
Mycobacteria
100%
Mycobacterium abscessus
100%
Nebulization
100%
Soft Tissue
50%
Antimicrobial Agent
50%
Antimicrobial Activity
50%
Broth Dilution
50%
Exhalation
50%
Human Pathogen
50%